Results 241 to 250 of about 86,997 (265)

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

OncoImmunology, 2016
Kazuya Ofuji, Nobuhiro Tsuchiya, Mari Takahashi   +2 more
exaly  

DNA vaccines and adjuvants

Immunological Reviews, 2004
openaire   +3 more sources

CpG DNA as a vaccine adjuvant

Expert Review of Vaccines, 2011
Christian Bode, Folkert Steinhagen, Takeshi Kinjo   +2 more
exaly  

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection

Expert Review of Vaccines, 2007
Derek T O'Hagan
exaly  

Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity

Human Vaccines and Immunotherapeutics, 2020
Sidhartha Chaudhury, Elizabeth H Duncan, Tanmaya Atre   +2 more
exaly  

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

Expert Review of Vaccines, 2010
Hana M El Sahly
exaly  

Vaccine adjuvant formulations: A pharmaceutical perspective

Seminars in Immunology, 2013
Luis A Brito, Padma Malyala, Derek T O'Hagan   +2 more
exaly  

Bioderived Polyelectrolyte Nanogels for Robust Antigen Loading and Vaccine Adjuvant Effects

Small, 2011
Sang-Mu Shim, Young-Woock Noh, Moon-Hee Sung   +2 more
exaly  

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant

Vaccine, 2016
Dimitar Sajkov, Yoshikazu Honda-Okubo, Samuel H Wilks   +2 more
exaly  

Starch microparticles as vaccine adjuvant

Expert Opinion on Drug Delivery, 2005
Ingvar Sjöholm
exaly